WIA
GILD icon

Wetzel Investment Advisors’s Gilead Sciences GILD Stock Holding History

Wetzel Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-384
Closed -$28.1K – 414
2024
Q2 		$28.1K Hold
384
– – 0.02% 298
2024
Q1 		$25.4K Sell
384
-529
-58% -$40.7K 0.02% 337
2023
Q4 		$74K Buy
+913
New +$71K 0.05% 204

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Wetzel Investment Advisors's GILD Position: Q3 2024 in Review

Wetzel Investment Advisors sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 384 shares — an estimated $28.1K sold.

Wetzel Investment Advisors first reported a position in GILD in Q4 2023 and held it in 3 quarters. The position peaked at $74K in Q4 2023. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Wetzel Investment Advisors reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • Wetzel Investment Advisors sold 384 Gilead Sciences shares in Q3 2024, an estimated $28.1K.
  • Wetzel Investment Advisors first reported a position in Gilead Sciences in Q4 2023 and held it in 3 quarters.
  • Wetzel Investment Advisors's Gilead Sciences position peaked at $74K in Q4 2023.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Wetzel Investment Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.